Advocating for mutually beneficial access to shelved compounds.
Pulley, Jill M
Advocating for mutually beneficial access to shelved compounds. [electronic resource] - Future medicinal chemistry 06 2018 - 1395-1398 p. digital
Publication Type: Editorial; Research Support, N.I.H., Extramural
1756-8927
10.4155/fmc-2018-0090 doi
Antidiuretic Hormone Receptor Antagonists--therapeutic use
Anxiety Disorders--drug therapy
Depressive Disorder, Major--drug therapy
Drug Industry
Drug Repositioning--methods
Humans
Indoles--therapeutic use
Pyrrolidines--therapeutic use
Receptors, Vasopressin--therapeutic use
Advocating for mutually beneficial access to shelved compounds. [electronic resource] - Future medicinal chemistry 06 2018 - 1395-1398 p. digital
Publication Type: Editorial; Research Support, N.I.H., Extramural
1756-8927
10.4155/fmc-2018-0090 doi
Antidiuretic Hormone Receptor Antagonists--therapeutic use
Anxiety Disorders--drug therapy
Depressive Disorder, Major--drug therapy
Drug Industry
Drug Repositioning--methods
Humans
Indoles--therapeutic use
Pyrrolidines--therapeutic use
Receptors, Vasopressin--therapeutic use